Tufton Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.83M Sell
61,711
-2,502
-4% -$202K 0.81% 42
2026
Q1
$5.56M Sell
64,213
-1,153
-2% -$110K 1.01% 33
2025
Q4
$6.28M Sell
65,366
-1,463
-2% -$142K 1.1% 35
2025
Q3
$6.36M Sell
66,829
-708
-1% -$65.1K 1.13% 34
2025
Q2
$5.89M Sell
67,537
-1,914
-3% -$162K 1.12% 37
2025
Q1
$6.24M Sell
69,451
-110
-0.2% -$9.84K 1.2% 35
2024
Q4
$5.56M Sell
69,561
-1,692
-2% -$146K 1.05% 38
2024
Q3
$6.41M Sell
71,253
-4,223
-6% -$355K 1.2% 34
2024
Q2
$5.94M Sell
75,476
-96
-0.1% -$7.87K 1.16% 35
2024
Q1
$6.59M Sell
75,572
-143
-0.2% -$12.2K 1.29% 33
2023
Q4
$6.24M Sell
75,715
-3,150
-4% -$240K 1.31% 34
2023
Q3
$6.18M Buy
78,865
+1,070
+1% +$89.6K 1.38% 32
2023
Q2
$6.85M Buy
77,795
+7,279
+10% +$627K 1.48% 32
2023
Q1
$5.68M Buy
70,516
+8,936
+15% +$728K 1.23% 35
2022
Q4
$4.79M Sell
61,580
-165
-0.3% -$13.4K 1.05% 40
2022
Q3
$4.99M Buy
61,745
+605
+1% +$54.4K 1.2% 36
2022
Q2
$5.49M Buy
61,140
+5,295
+9% +$537K 1.03% 41
2022
Q1
$6.2M Buy
55,845
+49,242
+746% +$5.2M 1% 41
2021
Q4
$683K Buy
6,603
+285
+5% +$33K 0.1% 86
2021
Q3
$791K Buy
6,318
+102
+2% +$13.2K 0.13% 80
2021
Q2
$771K Buy
6,216
+2,150
+53% +$270K 0.13% 82
2021
Q1
$480K Sell
4,066
-19
-0.5% -$2.23K 0.08% 93
2020
Q4
$478K Buy
4,085
+700
+21% +$77.1K 0.09% 91
2020
Q3
$351K Buy
+3,385
New +$340K 0.07% 99

Other funds holding MDT

Tufton Capital Management's MDT Position: Q2 2026 in Review

Tufton Capital Management reduced its Medtronic (MDT) stake by 3.9% in Q2 2026, selling an estimated $202K and leaving 61,711 shares worth $4.83M. The position accounts for 0.81% of the portfolio, ranked #42.

Tufton Capital Management first reported a position in MDT in Q3 2020 and has held it in 24 quarters since. The position peaked at $6.85M in Q2 2023. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Tufton Capital Management held 61,711 shares of Medtronic worth $4.83M as of Q2 2026.
  • Tufton Capital Management sold 2,502 Medtronic shares in Q2 2026, an estimated $202K.
  • Medtronic made up 0.81% of Tufton Capital Management's portfolio in Q2 2026, its #42 holding.
  • Tufton Capital Management first reported a position in Medtronic in Q3 2020 and has held it in 24 quarters since.
  • Tufton Capital Management's Medtronic position peaked at $6.85M in Q2 2023.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Tufton Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.